GL1X · GenesisL1 explorer

MolNFT v1 · #80420 · protein

Crystal structure of broad and potent HIV-1 neutralizing antibody PGT127 in complex with MAN9

3TWC · PGT127 light chain, ig lambda-2 chain C regions: “Crystal structure of broad and potent HIV-1 neutralizing antibody PGT127 in complex with MAN9”. X-ray diffraction, 2 ligands (AML, MAN), 5 pockets (best druggability 0.66). MolNFT v1…

PDB
3TWC
Type
protein
Length
439 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
PGT127 light chain, ig lambda-2 chain C regions; PGT127 heavy chain, ig gamma-1 chain C…
UniProt
P0CG05, P01857
Ligands
AML, MAN
Pockets
5 · best druggability 0.66

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LPGT127 light chain, ig lambda-2 chain C regionsprotein2087% helix, 51% strandP0CG05
HPGT127 heavy chain, ig gamma-1 chain C regionprotein2316% helix, 52% strandP01857

Ligands and binding sites

  • AML · Amylamine · ligand · chains H
  • MAN · alpha-D-mannopyranose · sugar · 8 copies · chains L, H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16010.660.7649empty
2770.420.8019empty
31580.410.7428empty
4780.400.7821empty
5630.280.7319empty

Interfaces

1 interface between chains.

  • L–H · 1853 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 1 modified (disulfide, cyclization).

Compared structures

  • 3TWC · Crystal structure of broad and potent HIV-1 neutralizing antibody PGT127 in complex with… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.